LS Investment Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,651
| Closed | -$83K | – | 993 |
|
|
2020
Q2 | $83K | Hold |
1,651
| – | – | 0.01% | 1041 |
|
|
2020
Q1 | $85K | Hold |
1,651
| – | – | 0.01% | 950 |
|
|
2019
Q4 | $102K | Buy |
1,651
+1,123
| +213% | +$69.4K | 0.01% | 1109 |
|
|
2019
Q3 | $32K | Hold |
528
| – | – | ﹤0.01% | 1419 |
|
|
2019
Q2 | $45K | Hold |
528
| – | – | ﹤0.01% | 1336 |
|
|
2019
Q1 | $50K | Hold |
528
| – | – | ﹤0.01% | 1299 |
|
|
2018
Q4 | $37K | Sell |
528
-2,458
| -82% | -$172K | ﹤0.01% | 1348 |
|
|
2018
Q3 | $255K | Sell |
2,986
-678
| -19% | -$57.9K | 0.01% | 742 |
|
|
2018
Q2 | $425K | Buy |
3,664
+34
| +0.9% | +$3.94K | 0.03% | 566 |
|
|
2018
Q1 | $294K | Sell |
3,630
-84
| -2% | -$6.8K | 0.02% | 692 |
|
|
2017
Q4 | $218K | Buy |
3,714
+1,345
| +57% | +$78.9K | 0.01% | 849 |
|
|
2017
Q3 | $111K | Buy |
2,369
+561
| +31% | +$26.3K | 0.01% | 1123 |
|
|
2017
Q2 | $65K | Hold |
1,808
| – | – | ﹤0.01% | 1273 |
|
|
2017
Q1 | $56K | Buy |
1,808
+1,325
| +274% | +$41K | ﹤0.01% | 1297 |
|
|
2016
Q4 | $16K | Hold |
483
| – | – | ﹤0.01% | 1605 |
|
|
2016
Q3 | $13K | Hold |
483
| – | – | ﹤0.01% | 1619 |
|
|
2016
Q2 | $11K | Hold |
483
| – | – | ﹤0.01% | 1631 |
|
|
2016
Q1 | $14K | Hold |
483
| – | – | ﹤0.01% | 1566 |
|
|
2015
Q4 | $16K | Hold |
483
| – | – | ﹤0.01% | 1546 |
|
|
2015
Q3 | $17K | Buy |
+483
| New | +$17K | ﹤0.01% | 1522 |
|